Evidence map›Paper›PMID 38498792›Full record

GuidelineJournal of clinical oncology : official journal of the American Society of Clinical Oncology2024

Vaccination of Adults With Cancer: ASCO Guideline.

Mini Kamboj, Kari Bohlke, Deana M Baptiste, Kieron Dunleavy, Abbey Fueger, Lee Jones, Amar H Kelkar, Lisa Y Law, Kristine B LeFebvre, Per Ljungman and 7 more

Open access · greenAbstract readPractice GuidelineSystematic Review
In one paragraph

Guideline in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 5 pooled it
25.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 5 syntheses or guidelines pooled it, 89 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Guideline
  4. Pooled it
  5. Vaccines for preventing infections in adults with solid tumours.The Cochrane database of systematic reviews · 2025
    Pooled it
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Active recruitment for vaccination of patients with solid-organ cancer through the surgical pathway.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  17. Article
  18. Review
  19. Article
  20. Current Vaccination Principles and Practices in Adult Cancer Patients.Journal of clinical practice and research · 2026
    Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 17 institutions in 3 countries.

Mini KambojMemorial Sloan Kettering Cancer Center, Weill Cornell Medical College, New York, NY.
Kari BohlkeAmerican Society of Clinical Oncology, Alexandria, VA.ORCID 0000-0003-1529-7903
Deana M BaptisteAmerican Cancer Society, Atlanta, GA.
Kieron DunleavyMedStar Georgetown University Hospital, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC.
Abbey FuegerThe Leukemia and Lymphoma Society, Rye Brook, NY.
Lee JonesFight Colorectal Cancer, Arlington, VA.ORCID 0000-0003-2454-5374
Amar H KelkarHarvard Medical School, Dana Farber Cancer Institute, Boston, MA.ORCID 0000-0001-7627-8509
Lisa Y LawKaiser Permanente, Roseville, CA.ORCID 0000-0001-7343-8212
Kristine B LeFebvreOncology Nursing Society, Pittsburgh, PA.ORCID 0000-0002-8357-8822
Per LjungmanKarolinska Comprehensive Cancer Center, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-8281-3245
Eric D MillerThe Ohio State University Comprehensive Cancer Center, Columbus, OH.ORCID 0000-0002-4931-3521
Larissa A MeyerThe University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-2687-7463
Heather N MooreDuke University Medical Center, Durham, NC.ORCID 0000-0002-0619-3267
Heloisa P SoaresHuntsman Cancer Institute at the University of Utah, Salt Lake City, UT.ORCID 0000-0002-5185-2583
Randy A TaplitzCity of Hope Comprehensive Cancer Center, Duarte, CA.ORCID 0000-0002-0109-5991
Edom S WoldetsadikAddis Ababa University, Addis Ababa, Ethiopia.ORCID 0000-0003-0405-5474
Elise C KohnCancer Therapy Evaluation Program, National Cancer Institute, Rockville, MD.
Addis Ababa University · ETAmerican Cancer Society · USAmerican Society of Clinical Oncology · USCity of Hope · USDuke Medical Center · USGeorgetown University · USHarvard University · USKaiser Permanente Roseville Medical Center · USKarolinska University Hospital · SELeukemia and Lymphoma Society · USMemorial Sloan Kettering Cancer Center · USNational Cancer Institute · USOncology Nursing Society · USPhiladelphia Fight · USThe Ohio State University · USThe University of Texas MD Anderson Cancer Center · USUniversity of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo guide the vaccination of adults with solid tumors or hematologic malignancies.

methodsA systematic literature review identified systematic reviews, randomized controlled trials (RCTs), and nonrandomized studies on the efficacy and safety of vaccines used by adults with cancer or their household contacts. This review builds on a 2013 guideline by the Infectious Disease Society of America. PubMed and the Cochrane Library were searched from January 1, 2013, to February 16, 2023. ASCO convened an Expert Panel to review the evidence and formulate recommendations.

resultsA total of 102 publications were included in the systematic review: 24 systematic reviews, 14 RCTs, and 64 nonrandomized studies. The largest body of evidence addressed COVID-19 vaccines. RECOMMENDATIONS: The goal of vaccination is to limit the severity of infection and prevent infection where feasible. Optimizing vaccination status should be considered a key element in the care of patients with cancer. This approach includes the documentation of vaccination status at the time of the first patient visit; timely provision of recommended vaccines; and appropriate revaccination after hematopoietic stem-cell transplantation, chimeric antigen receptor T-cell therapy, or B-cell-depleting therapy. Active interaction and coordination among healthcare providers, including primary care practitioners, pharmacists, and nursing team members, are needed. Vaccination of household contacts will enhance protection for patients with cancer. Some vaccination and revaccination plans for patients with cancer may be affected by the underlying immune status and the anticancer therapy received. As a result, vaccine strategies may differ from the vaccine recommendations for the general healthy adult population vaccine.Additional information is available at www.asco.org/supportive-care-guidelines.

Indexed as

COVID-19COVID-19 VaccinesNeoplasmsVaccinationAdultHumansSARS-CoV-2COVID-19 Vaccines

Identifiers

PMID38498792
PMCPMC11095883
OpenAlexW4392969918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.